ArticleCancer biomarkers : section A of Disease markers2022

Downregulation of ASF1B inhibits tumor progression and enhances efficacy of cisplatin in pancreatic cancer.

Jae Hyeong Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.